Skip to main content
Caplight Logo









Origincell Technology Group

Origincell Technology Group

Private
ShanghaiHealthcare & Life Scienceshttps://www.origincell.com/

Last Round

Private Equity

Apr 9, 2026

Est. Valuation

$210.1M

Total Funding Raised

$751.69M

Company Overview

Origincell Technology Group is a biotechnology company that provides cell banking services, automated biological sample storage equipment, and develops tumor immunotherapy solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

biobankingcell bankingcryopreservationautomated sample storagebiotech equipmentcold chain storagebiobank softwarestem cell storagecryogenic storagelab automation5G IoTdigital twinpredictive maintenancebiotech infrastructuresmart lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Origincell Technology Group Comparables

Compare Origincell Technology Group with similar companies based on industry and business-model similarity.

Origincell Technology Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genepoint Technologies Co., Ltd.
84%
Haier Smart Home
77%
ASKION GmbH
77%

Origincell Technology Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityApr 9, 2026
Series B ExtensionFeb 28, 2023
Series BJul 1, 2022
Series AMay 30, 2022
Series AMar 14, 2022
Series A
Jan 18, 2021

Origincell Technology Group Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2023

    Grew 45% QoQ from 11 to 16 employees.

  • Feb 28, 2023

    $45M round led by Qatar Investment Authority and RTW Investments.

Origincell Technology Group Filings

Explore SEC and related filing metadata, where available.

Origincell Technology Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Origincell Technology Group's valuation, stock price, and market status.

Is Origincell a public or private company?

Origincell is a private company.

What is the current stock price of Origincell?

Origincell is a private company with no public stock price. No recent secondary market data is available.

How much is Origincell worth (valuation)?

Origincell's valuation is estimated at $210.1M based on funding round data.

Can I buy Origincell stock?

Origincell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Origincell's last funding round?

Origincell's most recent funding round was Series A on May 30, 2022.

Who are the main investors in Origincell?

Key investors in Origincell include Yijing Capital, 上海张江(集团)有限公司, Qiming Venture Partners.

Will Origincell IPO soon?

No public IPO plans have been announced for Origincell.

How can I track Origincell secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Origincell's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range2
Year Founded2014
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?